PAR3 Blocking Peptide for STJ502116 peptide (STJ504531)

SKU:
STJ504531-250

Shipping:
Free Shipping
Current Stock:
Applications: Immunodepletion/Immunocompetition
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: PAR3 Blocking Peptide for STJ502116 is synthetically produced from the 1-100 sequence and is suitable for use in western blot applications.
Formulation: Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: F2rl3
Gene ID: 14065
Uniprot ID: PAR4_MOUSE
Immunogen Region: 1-100
Specificity: This blocking peptide is recommended for use in combination with PAR3 antibody, STJ502116
Immunogen: Synthetic peptide taken within amino acid region 1-100 on mouse Proteinase-activated receptor 3 protein.
Tissue Specificity Highly expressed in the spleen. Slight expression in the heart, lung, skeletal muscle and kidney. No detectable expression in brain, liver or testis. Also detected in platelets.
Post Translational Modifications A proteolytic cleavage generates a new N-terminus that functions as a tethered ligand.
Function Receptor for activated thrombin or trypsin coupled to G proteins that stimulate phosphoinositide hydrolysis. May play a role in platelets activation.
Peptide Name Proteinase-Activated Receptor 4
Par-4
Coagulation Factor Ii Receptor-Like 3
Thrombin Receptor-Like 3
Database Links Reactome: R-MMU-375276
Reactome: -MMU-416476
Reactome: -MMU-456926
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Peptide Names Proteinase-Activated Receptor 4 protein
Par-4 protein
Coagulation Factor Ii Receptor-Like 3 protein
Thrombin Receptor-Like 3 protein
F2rl3 protein
Par4 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance